Joining me on today’s call are Sean Nolan, Taysha Gene Therapies, Inc.'s Chief Executive Officer; Sukumar Nagendran, ...

Dosed multiple Rett syndrome patients in REVEAL pivotal trial of TSHA-102, with enrollment advancing across multiple sites; on track to complete dosing in Q2 2026 Received FDA clearance to initiate ...

Asset-Level Financing -- Legal and financial advisers are structuring vehicles for investors to participate directly at the program level across the proprietary portfolio.

Dosed multiple Rett syndrome patients in REVEAL pivotal trial of TSHA-102, with enrollment advancing across multiple sites; on track to complete dosing in Q2 2026 Received FDA clearance to initiate AS ...

Membership in the Claude Partner Network is free and open to any organisation involved in bringing Claude to market ...

Thank you for joining us today for MindWalk Holdings Corp.'s Third Quarter Fiscal Year 2026 Earnings Call. MindWalk trades on the NASDAQ under the ticker HYFT. Today's call will be led by our Chief ...

Longtime Trump ally and openly gay “Special Presidential Envoy for Special Missions of the United States” Richard Grenell is stepping down from his leadership role at the John F. Kennedy Center for ...

Delcath Systems, Inc. (NASDAQ:DCTH) Q4 2025 Earnings Call Transcript February 26, 2026 Delcath Systems, Inc. beats earnings ...

PRESS RELEASEMarch 10, 2026 RENAULT GROUP LAUNCHES futuREady OPENING A NEW STRATEGIC ERA Renault Group is moving into high gear, turning the success story of the Renaulution plan into a success system ...

Leading a technology function with the assumption that one day it will be reviewed by people who have no history with it is simply good discipline.

A durable time‑to‑market advantage in hardware development comes from deliberately designing for scale from day one.